Attached files

file filename
8-K - FORM 8-K - Nexeo Solutions Holdings, LLCd541288d8k.htm

Exhibit 99.1

Nexeo Solutions Holdings, LLC

Management Adjusted EBITDA Reconciliation

(in thousands)

 

    Q3 FY12     Q4FY12     Q1FY13     Q2FY13     LTM Q2
FY13
    Pro Forma
3/31/2013

LTM (1)
 

Net Income (Loss) Attributable to Nexeo Solutions Holdings, LLC

  $ 6,601      $ (5,401   $ (14,674   $ 10,875      $ (2,599   $ 2,965   

Net Income (Loss) Attributable to Noncontrolling Interest

    —          —          159        (106     53        3,762   

Interest

    11,103        11,268        13,720        14,197        50,288        51,238   

Taxes

    766        555        757        1,072        3,150        6,325   

Depreciation and Amortization

    9,378        9,801        9,554        9,715        38,448        38,580   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

    27,848        16,223        9,516        35,753        89,340        102,870   

Management add-backs (2)

    7,467        9,707        7,477        5,803        30,454        30,454   

Non-cash charges (3)

    355        108        1,420        1,256        3,139        3,139   

Management fees (4)

    1,691        2,301        1,715        1,542        7,249        7,249   

Letter of credit fees not included in interest expense

    327        230        —          —          557        557   

Compensation expense related to management equity plan (non-cash)

    326        278        240        574        1,418        1,418   

Transitional pension and medical payments – Ashland employees (5)

    145        68        —          —          213        213   

Transaction and other one-time costs (6)

    804        3,572        9,262        1,426        15,064        15,064   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Management Adjusted EBITDA

  $ 38,963      $ 32,487      $ 29,630      $ 46,354      $ 147,434        160,964   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) Pro forma Management Adjusted EBITDA for the twelve months ended March 31, 2013 reflects the full contribution of Nexeo Plaschem for the applicable period, including 100% of the results of Nexeo Plaschem. The Company currently owns 60% of Nexeo Plaschem.
(2) One-time costs associated with integration, transition, restructuring and transformational activities.
(3) Non-cash charges include foreign exchange gains and losses and amortization charges associated with purchase accounting requirements related to the acquisition of Beijing Plaschem’s operations.
(4) Management, monitoring, consulting and leverage fees, per the agreement with TPG Capital, L.P.
(5) Transitional pension and medical payments owed to certain Ashland employees pursuant to the Agreement of Purchase and Sale, dated November 5, 2010 by and between Ashland and Nexeo Solutions, LLC (formerly TPG Accolade, LLC), as amended.
(6) Professional and transaction costs related to the acquisition of the global distribution business of Ashland, the China joint venture, other potential acquisitions and other one-time costs.